EVEX vs SRTA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SRTA Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Strata Critical Medical, Inc. Class A Common Stock (SRTA) driven by superior Valuation, Momentum & Technical, Options & Structure while EVEX counters with relative strength in Growth & Margin. Fundamentally, EVEX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SRTA at 71.1x Forward P/E and -4.7% operating margin (+50.3% YoY). In options structure, EVEX sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against SRTA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EVEX | SRTA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $597.7M | $515.4M | Larger Scale | EVEX |
| Trailing P/E Ratio Valuation | N/M | 138.9x | Lower Multiple | SRTA |
| Forward P/E Ratio Valuation | N/M | 71.1x | Lower Multiple | SRTA |
| Revenue Growth (YoY) Growth | +0.0% | +50.3% | Higher Growth | SRTA |
| Operating Margin (TTM) Profitability | 0.0% | -4.7% | Higher Margin | EVEX |
| Net Profit Margin Profitability | 0.0% | -8.8% | Higher Margin | EVEX |
| Return on Equity (ROE) Capital Efficiency | -300.9% | -7.5% | Higher ROE | SRTA |
| 52-Week Range Position Momentum | 8% ($1โ$5) | 56% ($4โ$6) | Stronger Trend | SRTA |
| Beta / 30D Volatility Risk Regime | 2.71ฮฒ ยท 96% Vol | 1.97ฮฒ ยท 82% Vol | Lower Realized Risk | SRTA |
| Unified Institutional Score Composite Signal | 41.3 / 100 (SELL) | 29.9 / 100 (SELL) | Higher Composite | EVEX |